| Protocol No. | Title | Status |
| 06-0199-04 | Phase III Randomized Study of Chimeric Antibody 14.18 (CH14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue | Open |
| 06-0250-04 | A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma | Open |
| 06-0406-10 | A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated with Chemotherapy and Prednisone | Open |
| 08-0071-10 | COG ANBL0531: Response and Biology-Based Therapy for Intermediate-Risk Neuroblastoma | Open |
| 08-0327-10 | COG ANBL0532 Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma | Open |
| 10-0222-04 | Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (RTOG 0631) | Open |
| 12-0557-04 | A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects with Brain Metastases from Non-Small Cell Lung Cancer (M10-897) | Open |
| 12-0909-04 | A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma | Open |
| 13-0005-04 | RTOG 1205 Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma | Open |
| 20111531 | An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
PROTOCOL NO.: CDX110-04 (ACT IV)
| Open |
| COGAGCT0521 | Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521) | Open |